Exercise Intolerance in Obstructive Sleep Apnea Syndrome Patients
NCT ID: NCT00837018
Last Updated: 2013-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2005-06-30
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The anomalies in the exercise of patients with OSAS could be due to metabolic changes (insulin resistance and oxidative stress) and cardiovascular (impaired vascular reactivity).
Our goal is both to determine whether these anomalies exist in patients with OSAS not obese, consider their relationship with the alteration of exercise capacity, and their reversibility in conventional PPC or by using the effects of physical activity regular.In this study Objectives: To establish whether the metabolic and vascular abnormalities associated with OSAS are associated with decreased parameters of physical fitness in relation to witnesses matched for age, sex and body mass index. Determine the effects of a re-training exercise on these parameters compared to the reference treatment, continuous positive pressure.
Main objective: To compare the exercise capacity of OSAS patients compared with that of witnesses matched for age, sex and body mass index.
Secondary objectives: To compare the effect of conventional treatment by continuous positive pressure (CPP) on cardiovascular and metabolic abnormalities of OSAS, with a therapeutic modality most original, physical activity.
Methodology: Test physiopathological parallel group, controlled, randomized.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of an Individualized Training Program on Severity Markers of Obstructives Sleep Apnea/Hypopnea Syndrome (OSAS)
NCT01256307
Effects of Physical Activity on OSA Severity Based on the Level of Fluid Shift
NCT04623463
Strengthening Inspiratory and Oropharyngeal Muscles in Moderate Obstructive Sleep Apnea Hypopnea Syndrome
NCT06471751
Effect of Exercise Training on Obstructive Sleep Apnea Syndrome Severity
NCT02463890
Potential Mechanism of Exercise Impairment in OSA
NCT02505594
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Expected Total Enrollment : 45 patients + 15 control subjects
Tested treatment : Physical exercise program (45 minutes, 3 times a week) Reference treatment : continuous positive airway pressure Treatment duration : 12 weeks (3 months) Total study duration : 2 years
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Physical exercise program
45 min, 3 times a week
physical exercise program
45 min, 3times a week
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
physical exercise program
45 min, 3times a week
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Genders Eligible for Study: Both
* Non obese : body mass index (BMI \< 30 kg/m2)
* Sedentary subjects : less physical activity than 30 minutes 3 time a week
* and VOORIPS physical activity level questionnaire score \< 9.
Obstructive sleep apnea syndrome (OSAS) patients :
* Recently diagnosed (\< 3 months)
* AHI \> 30 / hour (polysomnographic monitoring measurement)
Exclusion Criteria
* Cardiovascular pathology (except controlled hypertension)
* Pathology interacting with physical activity
* Diabetes (known or treated)
* Other participation to a clinical trial at the same
40 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AGIR à Dom
OTHER
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bernard Wuyam, doctor
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Grenoble
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU, medecine du sport
Grenoble, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DGS 2005/0312
Identifier Type: REGISTRY
Identifier Source: secondary_id
0520
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.